Risk of grade 3-4 diarrhea and mucositis in colorectal cancer patients receiving anti-EGFR monoclonal antibodies regimens: A meta-analysis of 18 randomized controlled clinical trials

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Risk of grade 3-4 diarrhea and mucositis in colorectal cancer patients receiving anti-EGFR monoclonal antibodies regimens: A meta-analysis of 18 randomized controlled clinical trials
Authors
Keywords
Anti-egfr monoclonal antibodies, Cetuximab, Panitumumab, Colorectal cancer, Adverse events, Diarrhoea, Mucositis, Pharmacovigilance, Systematic review, Meta-analysis
Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 96, Issue 2, Pages 355-371
Publisher
Elsevier BV
Online
2015-06-25
DOI
10.1016/j.critrevonc.2015.06.004

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.